Harrow Health Inc - ESG Rating & Company Profile powered by AI
This Disclosure rating covers 17 United Nations Sustainable Development Goals including: 'Clean Water & Sanitation', 'Decent Work & Economic Growth' and 'Partnerships for the Goals'. Alternative companies in the scoring industry group for Harrow Health Inc are shownin the table. This webpage of Harrow Health Inc is prepared by All Street Sevva using leading NLP.
Harrow Health Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.2; made up of an environmental score of 8.0, social score of 1.3 and governance score of 5.7.
5.2
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 912 | Vivanza Biosciences Ltd | 5.3 | High |
| 912 | ValiRx PLC | 5.3 | High |
| 958 | Harrow Health Inc | 5.2 | High |
| 958 | Altimmune Inc | 5.2 | High |
| 958 | Agios Pharmaceuticals Inc | 5.2 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Harrow Health Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Harrow Health Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Harrow Health Inc report the average age of the workforce?
Sign up for free to unlockDoes Harrow Health Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Harrow Health Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Harrow Health Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Harrow Health Inc offer flexible work?
Sign up for free to unlockDoes Harrow Health Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Harrow Health Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Harrow Health Inc conduct supply chain audits?
Sign up for free to unlockDoes Harrow Health Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Harrow Health Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Harrow Health Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Harrow Health Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Harrow Health Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Harrow Health Inc disclose water use targets?
Sign up for free to unlockDoes Harrow Health Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Harrow Health Inc have a product recall in the last two years?
Sign up for free to unlockDoes Harrow Health Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Harrow Health Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Harrow Health Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Harrow Health Inc disclose parental leave metrics?
Sign up for free to unlockDoes Harrow Health Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Harrow Health Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Harrow Health Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Harrow Health Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Harrow Health Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Harrow Health Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Harrow Health Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Harrow Health Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Harrow Health Inc disclose its waste policy?
Sign up for free to unlockDoes Harrow Health Inc report according to TCFD requirements?
Sign up for free to unlockDoes Harrow Health Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Harrow Health Inc disclose energy use targets?
Sign up for free to unlockDoes Harrow Health Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Harrow Health Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Harrow Health Inc
These potential risks are based on the size, segment and geographies of the company.
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products. Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California.